Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,296 | 69 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $207.53 | 12 | $0 (2024) |
| Alkermes, Inc. | $120.98 | 7 | $0 (2024) |
| Lilly USA, LLC | $115.51 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $114.66 | 2 | $0 (2022) |
| Vanda Pharmaceuticals Inc. | $101.34 | 3 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $80.71 | 5 | $0 (2024) |
| Lundbeck LLC | $61.87 | 4 | $0 (2023) |
| Novo Nordisk Inc | $60.95 | 3 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $56.79 | 3 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $55.21 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $530.99 | 28 | Vanda Pharmaceuticals Inc. ($101.34) |
| 2023 | $357.78 | 22 | Lilly USA, LLC ($68.99) |
| 2022 | $306.59 | 18 | ABBVIE INC. ($85.36) |
| 2017 | $100.36 | 1 | AstraZeneca Pharmaceuticals LP ($100.36) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: VACCINE | ||||||
| 10/31/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Neuropsychiatry | ||||||
| 10/09/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $39.41 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/08/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Bone Health | ||||||
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Neuropsychiatry | ||||||
| 08/27/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Neuroscience | ||||||
| 08/14/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $36.60 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 08/07/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: CNS | ||||||
| 08/06/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/24/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: CNS | ||||||
| 07/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Central Nervous System | ||||||
| 07/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Neuropsychiatry | ||||||
| 07/10/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: VACCINE | ||||||
| 07/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: PSYCHIATRY | ||||||
| 05/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Diabetes | ||||||
| 04/09/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Psychology/Psychiatric | ||||||
| 03/13/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: VACCINE | ||||||
| 03/08/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: CNS | ||||||
| 02/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 14 | 819 | 1,129 | $104,170 | $41,812 |
| 2020 | 29 | 1,667 | 2,504 | $196,590 | $69,141 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 163 | 350 | $56,568 | $26,328 | 46.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 68 | 95 | $10,614 | $5,468 | 51.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 14 | 14 | $2,744 | $1,731 | 63.1% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 12 | 12 | $2,232 | $1,469 | 65.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $4,233 | $1,342 | 31.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 82 | 92 | $4,876 | $971.52 | 19.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 61 | 65 | $4,745 | $870.35 | 18.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 93 | 110 | $4,290 | $854.70 | 19.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 41 | 45 | $4,140 | $756.00 | 18.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 123 | 174 | $2,088 | $522.00 | 25.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 51 | 51 | $2,703 | $495.21 | 18.3% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2021 | 40 | 44 | $2,200 | $396.88 | 18.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2021 | 40 | 46 | $2,162 | $389.16 | 18.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 14 | 14 | $575.00 | $217.65 | 37.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 165 | 422 | $67,942 | $29,208 | 43.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 110 | 202 | $22,220 | $8,935 | 40.2% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 23 | 23 | $7,668 | $5,185 | 67.6% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 65 | 65 | $8,594 | $3,964 | 46.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 32 | 32 | $7,968 | $2,901 | 36.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 25 | 25 | $4,850 | $2,709 | 55.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 127 | 154 | $11,242 | $2,035 | 18.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 149 | 190 | $10,070 | $1,992 | 19.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2020 | 87 | 113 | $10,396 | $1,885 | 18.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 162 | 232 | $9,048 | $1,790 | 19.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 88 | 88 | $3,606 | $1,364 | 37.8% |
About Dr. Greg Link, DO
Dr. Greg Link, DO is a Family Medicine healthcare provider based in Bolivar, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871692798.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Greg Link, DO has received a total of $1,296 in payments from pharmaceutical and medical device companies, with $530.99 received in 2024. These payments were reported across 69 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,296).
As a Medicare-enrolled provider, Link has provided services to 2,486 Medicare beneficiaries, totaling 3,633 services with total Medicare billing of $110,953. Data is available for 2 years (2020–2021), covering 43 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Bolivar, MO
- Active Since 09/21/2006
- Last Updated 09/26/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1871692798
Products in Payments
- VRAYLAR (Drug) $154.95
- ARISTADA (Drug) $102.29
- HETLIOZ (Drug) $101.34
- FARXIGA (Drug) $100.36
- REXULTI (Drug) $93.88
- TRULICITY (Drug) $69.61
- INGREZZA (Drug) $55.21
- GARDASIL (Biological) $51.76
- ABILIFY MAINTENA (Drug) $48.70
- SPRAVATO (Drug) $41.16
- Austedo XR (Drug) $38.97
- Rybelsus (Drug) $37.82
- NURTEC ODT (Drug) $30.33
- JARDIANCE (Drug) $26.95
- Ozempic (Drug) $23.13
- MAVYRET (Drug) $22.90
- Auvelity (Drug) $21.33
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $20.39
- MOUNJARO (Drug) $18.95
- LYBALVI (Drug) $18.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bolivar
Michiel Rudder, Fnp Msw, FNP MSW
Family Medicine — Payments: $11,265
Mr. Ronald Vance, M.d, M.D
Family Medicine — Payments: $4,550
Mrs. Laura Vance, M.d, M.D
Family Medicine — Payments: $4,424
Mr. William Donnell, M.d, M.D
Family Medicine — Payments: $2,693
Kristopher Kaufmann, Do, DO
Family Medicine — Payments: $2,583
Mark Hillyer, Md, MD
Family Medicine — Payments: $2,483